Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Moeller

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Cancer|March 14, 2020
Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysisJames R Broughman, David D Xiong, Benjamin J Moeller, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Cancer|March 14, 2020
Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysisJames R Broughman, David D Xiong, Benjamin J Moeller, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Pageof 5